Inventor · disambiguated record
Adrian Gilbert
Also filed as: GILBERT ADRIAN
6 granted patents·15 pending applications·227 citations·filing 1998–2014
85Inventor score
Top patents by PatentIndex Score
21 records- 0190US7989473B2Stable laquinimod preparationsTEVA PHARMA·Filed 2007·Granted Aug 2, 2011·21 cites·37 claims
- 0290US6214791B1Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1YEDA RES & DEV·Filed 1998·Granted Apr 10, 2001·125 cites·15 claims
- 0387US7022663B2Oral, nasal and pulmonary dosage formulations of copolymer 1YEDA RES & DEV·Filed 2001·Granted Apr 4, 2006·65 cites·51 claims
- 0485US8383645B2Stable laquinimod preparationsTEVA PHARMA·Filed 2012·Granted Feb 26, 2013·9 cites·21 claims
- 0569US8022104B2Formulations of ladostigil tartrateYISSUM RES DEV CO·Filed 2006·Granted Sep 20, 2011·1 cites·11 claims
- 0667US7294687B2Parenteral formulations of a peptide for the treatment of systemic lupus erythematosusTEVA PHARMA·Filed 2004·Granted Nov 13, 2007·6 cites·25 claims
- 0764US2015031774A1Rasagiline orally disintegrating compositionsPATASHNIK SHULAMIT·Filed 2014·Application pending·0 cites
- 0860US2008287366A1Parenteral formulations of a peptide for the treatment of systemic lupus erythematosusTEVA PHARMA·Filed 2007·Application pending·0 cites
- 0959US2009111892A1Rasagiline Orally Disintegrating CompositionsPATASHNIK SHULAMIT·Filed 2005·Application pending·0 cites
- 1056US2009169559A1Parenteral formulations of peptides for the treatment of systemic lupus erythematosusTEVA PHARMA·Filed 2008·Application pending·0 cites
- 1155US2012238636A1Rasagiline orally disintegrating compositionsPATASHNIK SHULAMIT·Filed 2011·Application pending·0 cites
- 1254US2008107729A1Orally disintegrating compositionsSPI PHARMA INC·Filed 2007·Application pending·0 cites
- 1352US2004175423A1Sustained release formulation of N- (2-propylpentanoyl) glycinamide and related compoundsFiled 2004·Application pending·0 cites
- 1451US2004176463A1Immediate release formulation of n-(2-propylpentanoyl)glycinamideFiled 2004·Application pending·0 cites
- 1548US2011251235A1Stable laquinimod preparationsTEVA PHARMA·Filed 2011·Application pending·0 cites
- 1646US2013023485A1Parenteral formulations of peptides for the treatment of systematic lupus erythematosusTEVA PHARMA·Filed 2012·Application pending·0 cites
- 1745US2005008634A1Parenteral formulations of peptides for the treatment of systemic lupus erythematosusFiled 2004·Application pending·0 cites
- 1841US2011301234A1Formulations of ladostigil tartrateLICHT DANIELLA·Filed 2011·Application pending·0 cites
- 1941US2003147957A1Dual release formulation comprising levodopa ethyl ester and a decarboxylase inhibitor in immediate release layer with levodopa ethyl ester and a decarboxylase inhibitor in a controlled release coreFiled 2002·Application pending·0 cites
- 2038US2006018957A1Pharmaceutical dosage forms including rasagilineLERNER E I·Filed 2005·Application pending·0 cites
- 2133US2003152628A1Dual release formulation comprising levodopa ethyl ester and a decarboxylase inhibitor in an immediate-release layer with levodopa ethyl ester in a controlled release coreFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Adrian Gilbert files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →